A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
DHA-derived lipid compounds reduced gum inflammation and bone loss in a rat periodontitis model by suppressing NF-κB and STAT3 signaling.
In children with obesity, combined omega-3/omega-9 supplementation showed the most lasting improvement in insulin resistance, though baseline health and weight loss were bigger drivers than supplement type.
Krill oil's phospholipid-bound omega-3s, low contaminant profile, and added nutrients like choline and astaxanthin may support multiple aspects of healthy aging.
A research review links dietary DHA/EPA to multiple brain-aging pathways, with the clearest benefits seen in people who start with low omega-3 status.
Omega-3 fatty acids show biological plausibility for calming inflammation in IgA nephropathy, but clinical evidence for protecting long-term kidney function remains weak and inconsistent.
An omega-3-derived compound blocked brain cancer cell invasion in simple lab tests but showed mixed results and unintended effects on healthy brain tissue in a more realistic combined tissue model.
Patients with the highest blood EPA levels at hospital admission had a lower risk of dying during hospitalization after a brain hemorrhage, with no evidence of increased bleeding-related harm.
In diabetic rats, omega-3 supplementation reduced oxidative stress and preserved kidney structure compared to untreated diabetic rats.
In diabetic mice, six months of krill oil supplementation improved blood sugar and insulin resistance while reducing inflammatory macrophage activity in fat tissue.